Chiari Malformation Type 2

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound
Status:
Not yet recruiting
Last Changed:
Jan 25, 2019
First Changed:
Jan 25, 2019
Disease(s):
Ultrasound Therapy; Complications
Intervention(s):
Therapeutic Ultrasound
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Status:
Completed
Last Changed:
May 22, 2012
First Changed:
Feb 1, 2010
Disease(s):
Healthy Volunteers
Intervention(s):
Rotigotine transdermal patch
A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Status:
Completed
Last Changed:
Nov 11, 2015
First Changed:
Aug 14, 2013
Disease(s):
Actinic Keratosis
Intervention(s):
LEO 43204 Formulation 1LEO 43204 Formulation 2LEO 43204 Formulation 1 Dose XLEO 43204 Formulation 1 Dose YLEO 43204 Formulation 2 Dose XXLEO 43204 Formulation 2 Dose YYPlacebo Formulation 1Placebo Formulation 2

Connect. Empower. Inspire.